<DOC>
	<DOCNO>NCT01634100</DOCNO>
	<brief_summary>The objective trial investigate effect concurrent administration rifampicin probenecid pharmacokinetics empagliflozin .</brief_summary>
	<brief_title>Drug-interaction Trial Healthy Subjects With Oral Administration Empagliflozin ( BI 10773 ) , Rifampicin Probenecid</brief_title>
	<detailed_description />
	<mesh_term>Rifampin</mesh_term>
	<mesh_term>Empagliflozin</mesh_term>
	<mesh_term>Probenecid</mesh_term>
	<criteria>Inclusion criterion : 1. healthy male female subject Exclusion criterion : 1. relevant deviation healthy condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>